Global Ophthalmoplegia Market
HealthcareServices

Ophthalmoplegia Market – Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Ophthalmoplegia Market In The Coming Years?

In the recent years, there has been robust growth in the market size for ophthalmoplegia. The market, which was valued at $1.68 billion in 2024, is projected to appreciate to $1.84 billion in 2025, marking a compound annual growth rate (CAGR) of 9.8%. The historical growth can be linked to a surge in neurological disorders, increasing volume of the elderly population, growth in specialist clinics and hospitals, escalated demand for prompt diagnosis and treatments, a rise in clinical trials, and the expansion in healthcare insurance coverage.

Significant expansion is anticipated in the ophthalmoplegia market size in the coming years, with a projected increase to $2.7 billion by 2029. This represents a compound annual growth rate (CAGR) of 9.9%. The growth expected in this period can be attributed to factors such as the increasing incidence of neurological issues, the rising aging demographic, heightened awareness surrounding eye movement disorders, increased healthcare spending, enhanced healthcare investments by leading players, and an expanding patient population afflicted with diabetes and hypertension. The forecast period is likely to see such major trends as advancements in diagnostic technologies, the advent of new therapeutic methods, strategic collaborations and partnerships, continued technological improvement in eye tracking devices, and the production of muscle-strengthening drugs.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22081&type=smp

What Drivers Are Accelerating Expansion Of The Ophthalmoplegia Market?

The anticipated surge in the ophthalmoplegia market is largely attributed to the escalating occurrence of neurological disorders. These conditions, which impact the nervous system, including the brain, spinal cord and nerves, could potentially lead to effects such as muscle weakness, coordination difficulties, and cognitive impairments. Factors such as genetic susceptibility, which contribute to conditions such as Alzheimer’s and Parkinson’s, along with lifestyle transformations like poor nutrition, lack of activity, and continuous stress, contribute to the increased incidence of neurological disorders. This progression eventually leads to neurodegeneration and diminished brain function. The role of ophthalmoplegia becomes crucial in diagnosing neurological disorders such as Alzheimer’s disease, multiple sclerosis, and strokes by revealing issues in eye muscle control, a likely indication of underlying nervous system anomalies. To illustrate, the Alzheimer’s Association, a US-based non-profit healthcare organization, stated in March 2023 that about 6.7 million Americans aged 65 and older are living with Alzheimer’s dementia, with predictions suggesting a rise to 13.8 million by 2060. Therefore, the escalating recurrence of neurological disorders is fuelling the expansion of the ophthalmoplegia market.

How Is The Global Ophthalmoplegia Market Broken Down By Segment?

The ophthalmoplegiamarket covered in this report is segmented –

1) By Type: External Opthalmoplegia; Internuclear Opthalmoplegia

2) By Treatment: Surgery; Drug Treatment

3) By End-User: Hospitals; Clinics; Ambulatory Clinics

Subsegments:

1) By External Ophthalmoplegia: Chronic Progressive External Ophthalmoplegia (CPEO); Myasthenic External Ophthalmoplegia; Mitochondrial Myopathy-Associated External Ophthalmoplegia

2) By Internuclear Ophthalmoplegia: Unilateral Internuclear Ophthalmoplegia; Bilateral Internuclear Ophthalmoplegia

Which Firms Are Making The Biggest Impact In The Ophthalmoplegia Market?

Major companies operating in the ophthalmoplegia market are Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Medline Industries Inc., Regeneron Pharmaceuticals Inc., Carl Zeiss AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Bayer AG, Santen Pharmaceutical Co. Ltd., Oculis Holding AG, Innovative Pharmaceuticals Pvt. Ltd., Clearside Biomedical Inc., Altacor Limited, Azura Ophthalmics Ltd., ViGeneron GmbH, Amritt Inc., GenSight Biologics SA, EyeBio Inc., Opthea Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/ophthalmoplegia-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Ophthalmoplegia Market?

North America was the largest region in the ophthalmoplegia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmoplegia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=22081&type=smp

Browse Through More Reports Similar to the Global Ophthalmoplegia Market 2025, By The Business Research Company

Ophthalmic Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report

Ophthalmic Medical Lasers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ophthalmic-medical-lasers-global-market-report

Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model